VIDEO: C5 inhibitor may slow progression of nAMD
Click Here to Manage Email Alerts
In this video, Rishi P. Singh, MD, staff surgeon at Cleveland Clinic Cole Eye Institute, associate professor of ophthalmology at Lerner College of Medicine, highlighted the GATHER1 update presented at the virtual American Academy of Ophthalmology annual meeting.
“We're aware that the alternative complement pathway plays a large role in the progression of patients with non-neovascular AMD or geographic atrophy, and there have been studies recently that are in phase 2 and 3 that have validated that inhibiting this pathway has really been beneficial to slow the progression and growth rate,” Singh said.
Collapse
D'Amico, D. Update on Avacincaptad Pegol for Geographic Atrophy. Presented at: AAO20 Virtual Scientific Program; Nov 13-15, 2020.
Read more about
Click Here to Manage Email Alerts